Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005
- 10 November 2006
- Vol. 24 (44-46) , 6656-6659
- https://doi.org/10.1016/j.vaccine.2006.05.050
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practiceAntiviral Research, 2005
- A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active siteJournal of General Virology, 2002
- Influenza A Viruses Lacking Sialidase Activity Can Undergo Multiple Cycles of Replication in Cell Culture, Eggs, or MiceJournal of Virology, 2000
- Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071Antimicrobial Agents and Chemotherapy, 1998
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993